Clinical Trials Directory

Trials / Completed

CompletedNCT01265459

Different Volumes of Durolane in Knee OA

Double-Blind, Randomized Study of Three Different Volumes of Durolane in Subjects With Osteoarthritis of the Knee

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
40 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to assess the safety and efficacy profiles of new single-injection volumes of Durolane in patients with knee OA.

Detailed description

To assess the safety and efficacy profiles of different volumes of Durolane in patients with knee OA and compare with the current standard single-injection of the product. The study aims to investigate whether different volumes of Durolane compared to the standard injection volume will improve the benefit/risk profile.

Conditions

Interventions

TypeNameDescription
DEVICEDurolane 3 ml, Durolane 4,5 ml, Durolane 6 mlDurolane is an intraarticular hyaluronic acid preparation

Timeline

Start date
2011-01-01
Primary completion
2011-09-01
Completion
2011-11-01
First posted
2010-12-23
Last updated
2022-09-22
Results posted
2014-01-20

Locations

3 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01265459. Inclusion in this directory is not an endorsement.